
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is projected to achieve long-term EPS growth and has recently seen success in its Cardiac Ablation Solutions business. With key growth drivers such as renal denervation and robotics, strategic investments and planned separation of its Diabetes division, the company has potential for upside potential. However, market competition and external factors could pose risks to the company's stock price and rating.
Bears say
Medtronic is facing a number of challenges, including inconsistent execution and quarterly results, a competitive landscape in the EP market, and uncertainty surrounding the stability of its TAVR volumes. Additionally, the company's dependence on government reimbursement and its growing reliance on state supplemental programs pose risks to its financial performance. While the company has a strong product pipeline, lower cash collections and potential margin expansion challenges could hinder its growth potential. Overall, we believe that these factors will prevent Medtronic from seeing P/E multiple expansion, and therefore we have a negative outlook on the stock.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares